Carbazochroom
  • CarbazochroomCarbazochroom

Carbazochroom

Carbazochroom kan de permeabiliteit van haarvaten verminderen, de krimp van het beschadigde capillaire uiteinde en hemostase bevorderen. Het wordt voornamelijk gebruikt voor bloedingen veroorzaakt door verhoogde capillaire permeabiliteit, zoals idiopathische purpura, retinale bloeding, chronische longbloeding, gastro-intestinale bloeding, epistaxis Chemicalbook, bloedspuwing , hematurie, aambeibloeding, baarmoederbloeding, hersenbloeding, enz. Het is minder effectief voor massale bloedingen en arteriële bloedingen. Hemostaticum, voor de ontwikkeling van paarse klassenziekte, erfelijke capillaire dilatatie en het voorkomen van long, nier, darm, hersenen, baarmoeder en andere bloedingen

Stuur onderzoek

Productomschrijving

Carbazochroom


Carbazochroom /Adrenosem CAS:69-81-8

Carbazochroom Chemical Properties
MF:C10H12N4O3
MW: 236,23
EINECS:200-717-0
Smeltpunt: 203° (dec)
Dichtheid: 1,63 ± 0,1 g/cm3 (voorspeld)
Pka: 12,38 ± 0,40 (voorspeld)
Merck: 14,172

Carbazochroom /Adrenosem CAS:69-81-8 Specificatie:

Item

Specificatie

Uiterlijk

Geelrood kristal of kristallijn poeder

Identificatie

Voldoet aan de eisen

Smeltpunt

222°C

Absorptie

1054 ~ 1130

Zware metalen

≤30ppm

Ijzer

≤60ppm

Chloride

€ 0,041%

Arseen

≤2ppm

Verlies bij drogen

≤1,0%

Redding bij ontsteking

€ 0,1%

Assay

≥98,0%


Carbazochroom /Adrenosem CAS:69-81-8 Introduction:
Carbazochroom is a hemostatic agent that promotes clotting, preventing blood loss from open wounds. It is an oxidation product of adrenaline which enhances the microcirculatory tone 4. In the future this may prevent excessive blood flow during surgical operations and the treatment of hemorrhoids, but research on effectiveness and severity of side effects remains inconclusive. It is not FDA-approved but is available as tablets or 
IM/SC-injecties bij de behandeling van bloedingen in een aantal landen.
Carbazochroom has been investigated for use in the treatment of non-surgical acute uncomplicated hemorrhoids in a mixture with Troxerutin, and this combination therapy demonstrated efficacy and safe tolerability either at a local or systemic level 1.

Carbazochroom /Adrenosem CAS:69-81-8 Function
1. Hemostatic. Carbazochroom is used for the expansion of hair type purple class, hereditary capillary expansion and prevention of lung, kidney, intestine, brain and uterine bleeding.
2. Carbazochroom can reduce the permeability of capillaries and promote the retraction of damaged capillaries to stop bleeding. Mainly used in capillary permeability increase due to bleeding, such as idiopathic purpura, retinal hemorrhage and chronic lung hemorrhage, gastrointestinal bleeding, epistaxis, haemoptysis, hematuria, hemorrhoids bleeding, uterine hemorrhage, cerebral hemorrhage, etc. The effect of hemorrhage and arterial hemorrhage is poor. Hemostatic medicine, used in the development of hair purple class, hereditary capillary expansion and prevention of lung, kidney, intestines, brain, uterus and other bleeding.

Carbazochroom /Adrenosem CAS:69-81-8 Application:
Carbazochroom can reduce the permeability of capillaries and promote the retraction of damaged capillaries and hemostasis. It is mainly used for bleeding caused by increased capillary permeability, such as idiopathic purpura, retinal hemorrhage, chronic pulmonary hemorrhage, gastrointestinal hemorrhage, nasal Chemicalbook epistaxis, hemoptysis, hematuria, hemorrhoid hemorrhage, uterine hemorrhage, cerebral hemorrhage, etc. It is less effective in treating massive bleeding and arterial bleeding. Hemostatic, used for persistent purple disease, hereditary capillary expansion and to prevent bleeding of lung, kidney, intestine, brain, uterus, etc



Hottags: Carbazochrome, fabrikanten, leveranciers, fabriek, China, gemaakt in China, goedkoop, korting, lage prijs

Gerelateerde categorie

Stuur onderzoek

Stel gerust uw vraag via onderstaand formulier. Wij zullen u binnen 24 uur antwoorden.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept